BSECompany Update5d ago · 14 Aug 2026, 04:01 pm

Statement of NIL deviation or variation for the quarter ended June 30, 2026

Shree Hari Chemicals Export Ltd · 524336

✦ AI SummaryResults

Shree Hari Chemicals Export Ltd has submitted a statement of NIL deviation or variation for the quarter ended June 30, 2026, as per Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Shree Hari Chemicals Export Ltd - 524336 - Statement Of NIL Deviation(S) Or Variation(S) For The Quarter Ended June 30, 2026.

Attachments (1)

📄

74e201e4-585a-4da1-9532-50cb206d1dc6.pdf

pdf

Download →
View document text
Date: August 14, 2026 The General Manager DCS - CRD BSE LIMITED Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip code: 524336 Dear Sir/Madam, Sub: Statement of deviation(s) or variation(s) for the quarter ended June 30, 2026. Ref.: Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) Pursuant to regulation 32 of the SEBI Listing Regulations, please note that there are no deviation(s) or variation(s) in respect of the utilization of the proceeds of the Preferential Issue of the Company during the quarter ended June 30, 2026. Accordingly, a NIL statement of deviation or variation is enclosed herewith as ‘Annexure A’ You are requested to kindly take the same on record. Please note further that the proceeds of the Preferential Issue have been fully utilized and there has been no deviations in the use of proceeds from the objects as stated in the explanatory statement to the notice for the Annual General Meeting held on September 27, 2024. Thanking you. Yours faithfully, FOR SHREE HARI CHEMICALS EXPORT LIMITED B.C. AGRAWAL Chairman & Managing Director DIN: 00121080 Annexure- A Statement of Deviation / Variation in utilisation of funds raised Name of listed entity SHREE HARI CHEMICALS EXPORT LIMITED Mode of Fund Raising Initial Public Offer / Rights Issues / Preferential Issues / QIP / Others Date of Raising Funds November 12, 2024, November 13, 2024, March 05, 2025, July 10, 2025 & July 11, 2025 Amount Raised Rs. 14,74,59,820/- Report filed for Quarter ended June 30, 2026 Monitoring Agency Not Applicable Monitoring Agency Name, if applicable Not Applicable Is there a Deviation / Variation in use of Nil funds raised If yes, whether the same is pursuant to change Not Applicable in terms of a contract or objects, which was approved by the shareholders If Yes, Date of shareholder Approval Not Applicable Explanation for the Deviation / Variation Not Applicable Comments of the Audit Committee after None review Comments of the auditors, if any Not Applicable Objects for which funds have been raised and Not Applicable where there has been a deviation, in the following table: Original Object Modified Original Modified Funds Amount of Remarks Object, if Allocation allocation, Utilised Deviation/Variation if any any (₹ in Crore) if any (₹ in Crore) for the quarter according to applicable object Not Applicable as no deviation from object. Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or (c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, etc. Signature: Name of Signatory BANKESH CHANDRA AGRAWAL Designation Chairman & Managing Director